LIVE/VIRTUAL ACTIVITIES

Bio Ascend – Designing CME Solutions For a Virtual World, Our Live and Virtual CME Activities Are Designed to Keep HCPs Educated.

Bio Ascend helps healthcare providers (HCPs) like you stay educated by providing the CME resources you need for continuing education. Our vast selection of activities is devoted entirely to solid tumor and hematologic malignancies – with engaging options in both in-person and virtual environments. Activities feature leading experts discussing the latest data and how to apply it to clinical practice, providing you with critical insight and direction on how to incorporate therapeutic advancements into your practice.

Satellite Symposia:
Experts Debate: Treatment Decisions in Relapsed/Refractory Multiple Myeloma

December 10, 2021 – Live/Virtual
Time: 11:00 AM – 1:30 PM EDT

There are no fees to register for this symposium

This live satellite symposium will take place preceding the 2021 ASH Annual Meeting and Exposition and will be presented by four renowned experts actively engaged in the care of patients with multiple myeloma. This symposium will also be live streamed for those who may not be able to attend in person.

Friday Satellite Symposium on Multiple Myeloma preceding the 63rd ASH Annual Meeting and Exposition.

Register for ASH MM Symposium
Agenda
11:00 AM
Welcome, Introductions, and Presession Survey - Dr. Sagar Lonial
11:10 AM
What is the Optimal Partner for CD38 Therapy in First Relapse?
  • IMID - Krina Patel, MD, MSc
  • PI - Dr. Saad Usmani
  • Panel Discussion and Rebuttals
11:40 AM

Is MRD Assessment Useful for Treatment Decisions?

  • Yes - Dr. Jeffrey Wolf
  • No - Dr. Sagar Lonial
  • Panel Discussion and Rebuttals 
12:10 PM
What is the Optimal Class of Agents for Triple Class Refractory MM?
12:40 PM

What is the Optimal Class of Agents for Triple Class Refractory MM?

  • Immunotherapy - Dr. Sagar Lonial
  • Small Molecules - Dr. Saad Usmani
  • Panel Discussion and Rebuttals 
1:10 PM

Audience Q&A with the Clinical Experts - Moderated by Dr. Sagar Lonial
1:20 PM

Recap of Key Points and Post-Session Survey - Dr. Sagar Lonial
1:30 PM

Conclusion
IMG 6263

Symposium Chair

Sagar Lonial, MD, FACP
Winship Cancer Institute of Emory University

Faculty

Krina Patel, MD, MSc
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Saad Usmani, MD, MBA, FACP
Memorial Sloan Kettering Cancer Center
New York, New York

Jeffrey Wolf, MD
University of California
San Francisco

Satellite Symposia:
Experts Debate: Treatment Decisions in Relapsed/Refractory Multiple Myeloma

December 10, 2021 – Live/Virtual
Time: 11:00 AM – 1:30 PM EDT

There are no fees to register for this symposium
IMG 6263

This live satellite symposium will take place preceding the 2021 ASH Annual Meeting and Exposition and will be presented by four renowned experts actively engaged in the care of patients with multiple myeloma. This symposium will also be live streamed for those who may not be able to attend in person.

Friday Satellite Symposium on Multiple Myeloma preceding the 63rd ASH Annual Meeting and Exposition.

Register for ASH MM Symposium

Symposium Chair

Sagar Lonial, MD, FACP
Winship Cancer Institute of Emory University

Faculty

Ajai Chari, MD
Icahn School of Medicine at Mount Sinai

Suzanne Lentzsch, MD, PhD
Herbert Irving Comprehensive Cancer Center
Columbia University

Jeffrey Wolf, MD
University of California San Francisco

Agenda
11:00 AM
Welcome, Introductions, and Pre-session Survey
11:10 AM
Debate 1: Targeting BCMA: CART vs Bispecific Antibodies vs Antibody Drug Conjugates
11:40 AM

Debate 2: Regimen Choice: Doublet vs Triplet
12:10 PM

Debate 3: What is the optimal partner for CD38 therapy in first relapse: 
IMID vs PI
12:40 PM

Debate 4: Is MRD assessment useful for treatment decisions:  Yes vs No
1:10 PM
Panel Discussion and Audience Q&A
1:20 PM
Recap of Key Points and Post-Session Survey
1:30 PM
Program Adjourns